CHPA Elects Board and Officers at Annual Executive Conference

Washington, D.C. (March 9, 2012)—Members of the board of directors of the Consumer Healthcare Products Association (CHPA) were elected at the association’s March 8-10 Annual Executive Conference. Paul L. Sturman, president and general manager, Pfizer Consumer Healthcare, was elected as the association’s chair. James J. Mackey, senior vice president, U.S. Region Head, Merck Consumer Care, was named chair-elect. Christopher D. DeWolf, president & chief executive officer, Lil’ Drug Store Products, Inc., will serve as immediate past chair. 

CHPA board members as of this election are:

  • Marylou W. Arnett, chief executive officer, Matrixx Initiatives, Inc.;*
  • Christopher B. Ascher, co-owner/president, B.F. Ascher & Company, Inc.;
  • J.P. Borneman, Ph.D, chairman & chief executive officer, Hyland’s, Inc.;
  • Maria Elisa Carvajal, general manager, Colgate Oral Pharmaceuticals, Colgate-Palmolive Company;*
  • Christopher B. Combe, chairman, Combe Incorporated;
  • Michael J. Donnantuono, president & chief operating officer, Blistex Inc.;
  • Gary R. Downing, chief executive officer, Insight Pharmaceuticals Corp.;
  • Scott R. Emerson, partner, DSE Healthcare Solutions, LLC;
  • Laurent Faracci, general manager, chief strategy & marketing officer, RB US, Reckitt  Benckiser LLC; *
  • Joseph F. Gordon, vice president, Marketing of OTC and Supplements, Bausch + Lomb;*
  • Zan Guerry, chief executive officer, Chattem, Inc.;
  • Timothy G. Hayes, president, Consumer Care North America, Bayer HealthCare LLC;
  • Jeffrey S. Himmel, chief executive officer, ChromaDex, Inc.;
  • Patrick Lockwood-Taylor, vice president, Personal Health Care, The Proctor & Gamble Company;
  • Patrick M. Lonergan, president, NUMARK Laboratories;
  • Colin I. Mackenzie, president, North America Consumer Healthcare, GlaxoSmithKline;
  • Matthew M. Mannelly, chief executive officer, Prestige Brands Holding, Inc.;
  • Roberto Marques, company group chairman North America, Consumer Companies, Johnson & Johnson;*
  • Daren Mazzucca, publisher, Midwest Living, Meredith Corporation;
  • Brian J. McNamara, division head, OTC, Novartis Consumer Health, Inc.;
  • James L. Medford, president, chief executive officer, and chairman of the board, Aaron Industries, Inc.;
  • Jeffrey R. Needham, executive vice president and general manager, Consumer Health Care, Perrigo Company;
  • Adam D. Raczkowski, president and chief operating officer, W.F. Young, Inc.;
  • Marc. L. Rovner, vice president & general manager, Consumer Health Care USA, Boehringer Ingleheim Pharmaceuticals, Inc.;
  • Jeff R. Rowan, president and chief executive officer, Fleet Laboratories;
  • Robert J. Sanders, Jr., executive vice president, general manager, SymphonyIRI Group;*
  • Bill Seiden, senior vice president, U.S. Sales & Marketing, Taro Pharmaceuticals U.S.A., Inc.;
  • James Silverman, CRO/vice president, Business Development; CARE Media Holdings Corp.;*
  • Mitchell Singer, president and chief executive officer, PL Developments;*
  • Randy M. Sloan, president and chief executive officer, Lornamead, Inc.;
  • Stephen H. Thong, Ph.D., director, Global Oral Care Research & Development, Church & Dwight Co., Inc.;*
  • Neill B. Walsdorf, Jr., president, Mission Pharmacal Company;
  • David J. Wendland, vice president, Hamacher Resource Group;
  • Steven B. Woolf, executive vice president & chief financial officer, Humco Holding Group, Inc.;
  • Akiyoshi Yoshida, Ph.D., president and chief executive officer, The Mentholatum Company;
  • Richard Zulman, president & chief executive officer, BestSweet, Inc.*

*denotes newly elected to this position 

Contact: Jenni Terry, 202.429.9260

CHPA is the 131-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.